Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs hydromorphone for postoperative analgesia in cesarean section and impact on postpartum depression
ChiCTR2200059451Phase 4Not yet recruiting
- Sponsor
- Yongzhou Central Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by Yongzhou Central Hospital. Primary endpoints: Pain visual analogue scale (VAS) and Edinburgh Depression Scale for Pregnancy. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2200059451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059451.